Royalty Pharma Balance Sheet (2019-2025) | RPRX

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Dec2019	Mar2020	Jun2020	Sep2020	Dec2020	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Assets
Current Assets
Cash & Equivalents	-0.04B	-0.09B	2.44B	1.55B	1.01B	0.71B	1.14B	1.80B	1.54B	1.79B	2.11B	0.99B	1.71B	1.98B	2.17B	0.94B	0.48B	0.84B	1.76B	0.95B	0.93B	1.09B	0.63B	0.94B	0.62B
Short-term Investments			0.03B	0.04B	0.07B	0.07B	0.07B	0.07B	0.07B	0.06B	0.36B	0.41B	0.00B	0.00B	0.01B	0.01B	0.02B	0.03B	0.04B	0.05B	0.06B	0.01B	0.01B	0.02B	0.02B
Cash & Current Investments	-0.04B	-0.09B	2.47B	1.60B	1.08B	0.78B	1.21B	1.87B	1.61B	1.86B	2.47B	1.40B	1.71B	1.98B	2.18B	0.94B	0.50B	0.87B	1.80B	1.00B	0.99B	1.10B	0.65B	0.96B	0.64B
Receivables - Other	0.03B		0.03B	0.03B	0.03B	0.03B	0.03B	0.06B	0.05B	0.05B	0.02B	0.02B	0.02B	0.02B	0.02B	0.02B	0.01B
Prepaid Assets	0.00B		0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.07B	0.09B	0.09B	0.00B	0.01B	0.01B	0.02B	0.01B	0.00B	0.00B	0.00B	0.00B	0.00B	0.01B	0.01B
Current Assets	0.83B		3.39B	2.78B	2.70B	2.42B	2.71B	2.78B	2.88B	2.98B	3.50B	2.34B	2.55B	2.63B	2.95B	1.73B	1.27B	1.56B	2.58B	1.79B	1.80B	1.84B	1.52B	1.85B	1.53B
Non-Current Assets
Long-Term Investments	0.38B		0.48B	0.64B	0.45B	0.44B	0.47B	0.47B	0.44B	0.42B	0.41B	0.41B	0.40B	0.38B	0.38B	0.38B	0.44B	0.47B	0.63B	0.66B	0.69B	0.34B	0.28B	0.30B	0.42B
Goodwill																							0.92B	0.92B	0.92B
Intangibles	0.05B		0.04B	0.03B	0.03B	0.02B	0.02B	0.01B	0.01B
Goodwill & Intangibles	0.05B		0.04B	0.03B	0.03B	0.02B	0.02B	0.01B	0.01B														0.92B	0.92B	0.92B
Other Non-Current Assets	0.01B			0.00B	0.01B	0.00B	0.01B	0.00B	0.00B	0.00B	0.03B	0.03B	0.03B	0.03B	0.03B	0.02B	0.01B	0.00B	0.03B	0.04B	0.03B	0.04B	0.09B	0.09B	0.08B
Non-Current Assets	11.62B		12.29B	13.21B	13.32B	13.50B	13.81B	14.96B	14.64B	14.40B	14.24B	15.33B	14.26B	14.44B	14.17B	14.13B	15.11B	14.57B	15.08B	16.25B	16.42B	15.77B	16.80B	17.50B	18.09B
Assets	12.45B		15.69B	15.99B	16.02B	15.91B	16.51B	17.73B	17.52B	17.38B	17.74B	17.67B	16.81B	17.07B	17.12B	15.86B	16.38B	16.13B	17.66B	18.04B	18.22B	17.61B	18.32B	19.35B	19.62B
Liabilities
Current Liabilities
Accounts Payables	0.01B		0.03B	0.02B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.02B	0.01B	0.01B	0.01B	0.01B	0.02B	0.01B	0.02B	0.02B	0.01B	0.04B	0.02B	0.04B	0.02B
Payables	0.01B		0.03B	0.02B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.01B	0.02B	0.01B	0.01B	0.01B	0.01B	0.02B	0.01B	0.02B	0.02B	0.01B	0.04B	0.02B	0.04B	0.02B
Accumulated Expenses					0.04B	0.01B	0.04B	0.02B	0.06B	0.01B	0.05B	0.01B	0.05B	0.01B	0.05B	0.01B	0.05B	0.01B	0.06B	0.04B	0.10B	0.02B	0.09B	0.03B	0.11B
Other Accumulated Expenses					0.02B		0.00B						0.01B				0.01B	0.01B	0.10B	0.03B	0.07B	0.02B	0.00B	0.00B	0.05B
Short term Debt	0.28B		0.18B	0.14B	0.13B	0.11B	0.12B	0.12B	0.11B	0.12B	0.12B	1.00B	1.00B	1.00B	1.00B					1.00B	1.00B	1.00B	1.00B	0.38B	0.38B
Total Current Liabilities	0.33B		0.45B	0.27B	0.31B	0.26B	0.28B	0.26B	0.17B	0.14B	0.18B	1.13B	1.17B	1.12B	1.17B	0.13B	0.16B	0.12B	0.28B	1.17B	1.25B	1.18B	1.21B	0.53B	0.64B
Non-Current Liabilities
Non-Current Debt	5.96B		5.73B	5.81B	5.82B	5.82B	5.83B	7.09B	7.10B	7.10B	7.11B	6.11B	6.12B	6.12B	6.13B	6.13B	6.14B	6.14B	7.60B	6.61B	6.61B	6.62B	7.00B	8.57B	8.57B
Minority Interest	0.04B		5.24B	5.35B	5.08B	4.95B	4.67B	4.59B	4.47B	4.36B	4.38B	4.26B	3.90B	3.87B	3.53B	3.45B	3.56B	3.36B	3.28B	3.39B	3.40B	3.10B	3.16B	3.21B	3.24B
Other Non-Current Liabilities	0.02B		0.11B	0.11B							0.04B	0.01B	0.00B	0.01B	0.01B	0.01B	0.00B	0.00B	0.03B	0.01B	0.01B	0.02B	0.47B	0.50B	0.58B
Total Non-Current Liabilities	6.29B		6.18B	6.08B	6.12B				7.27B		7.29B	7.25B	7.29B	7.24B	7.30B	6.26B	6.30B	6.26B	7.88B	7.78B	7.87B	7.80B	8.35B	9.22B	9.33B
Total Liabilities	6.31B	-7.16B	6.29B	6.19B	6.12B	6.08B	6.11B	7.35B	7.27B	7.24B	7.33B	7.26B	7.29B	7.25B	7.31B	6.27B	6.30B	6.27B	7.90B	7.78B	7.88B	7.82B	8.82B	9.73B	9.91B
Shareholder's Equity
Total Debt	6.24B		5.91B	5.95B	5.94B	5.93B	5.94B	7.21B	7.20B	7.22B	7.22B	7.11B	7.12B	7.12B	7.13B	6.13B	6.14B	6.14B	7.60B	7.61B	7.61B	7.62B	8.00B	8.95B	8.95B
Common Equity	6.14B	7.16B	9.39B	9.80B	9.90B	9.84B	10.41B	10.39B	10.25B	10.14B	10.41B	10.42B	9.53B	9.82B	9.81B	9.59B	10.08B	9.86B	9.75B	10.26B	10.34B	9.79B	9.50B	9.62B	9.71B
Shareholder's Equity	6.14B	7.16B	9.39B	9.80B	9.90B	9.84B	10.41B	10.39B	10.25B	10.14B	10.41B	10.42B	9.53B	9.82B	9.81B	9.59B	10.08B	9.86B	9.75B	10.26B	10.34B	9.79B	9.50B	9.62B	9.71B
Liabilities and Shareholders Equity	12.45B		15.69B	15.99B	16.02B	15.91B	16.51B	17.73B	17.52B	17.38B	17.74B	17.67B	16.81B	17.07B	17.12B	15.86B	16.38B	16.13B	17.66B	18.04B	18.22B	17.61B	18.32B	19.35B	19.62B
Treasury Shares															0.00B	0.01B	0.01B		0.00B	0.01B	0.01B		0.02B	0.02B	0.02B
Retained Earnings	2.83B		1.57B	1.81B	1.92B	1.92B	2.29B	2.32B	2.26B	2.22B	2.45B	2.50B	1.96B	2.22B	2.25B	2.13B	2.52B	2.43B	2.38B	2.76B	2.85B	2.48B	2.22B	2.30B	2.36B

Research Tools

Royalty Pharma Balance Sheet (2019-2025) | RPRX

Create an account

Sign In

Reset Password